Empirical Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Empirical Asset Management's ABBV Position: Q2 2026 in Review
Empirical Asset Management increased its AbbVie (ABBV) stake by 63% in Q2 2026, buying an estimated $463K and bringing the position to 5,575 shares worth $1.4M. The position accounts for 0.32% of the portfolio, ranked #91.
Empirical Asset Management first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Empirical Asset Management held 5,575 shares of AbbVie worth $1.4M as of Q2 2026.
- Empirical Asset Management bought 2,154 AbbVie shares in Q2 2026, an estimated $463K.
- AbbVie made up 0.32% of Empirical Asset Management's portfolio in Q2 2026, its #91 holding.
- Empirical Asset Management first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.